Cancer Markers

Description
Laboratories screening for multiple biomarkers demand a platform that gives more data without more cost or labor. xMAP® Technology offers a multiplex solution that boosts laboratory productivity in biomarker screening. xMAP offers a ‘liquid ELISA’ approach, enabling multiplexing of up to 100 analytes per sample well. In addition to research, xMAP Technology is ideal for diagnostic applications in clinical labs, as it allows for multi-analyte profiles with the ability to build internal controls into the various assays. Luminex's breakthrough approach offers comparable sensitivity to traditional ELISA-based systems, but with additional advantages including multiplexing, extended dynamic range, smaller sample size, and dramatically reduced workload.

Tests available from:

 

 Analytes
AFP (alpha-fetoprotein) Human 
alpha Fetoprotein Human 
beta2-MG Human 
CA 125 Human 
CA 15-3 Human 
CA 19-9 Human 
CA 242 Human 
CA 72-4 Human 
Cancer Antigen 125 Human 
Carcinoembryonic Antigen Human 
CEA (carcinoembryonic antigen) Human 
Cyfra21-1 Human 
f-PSA Human 
free-beta-hCG Human 
hCG Human 
hGH Human 
IGF-II Human 
Leptin Human 
MIF Human 
NSE Human 
Osteopontin Human 
PepsinogenI Human 
PepsinogenII Human 
Prolactin Human 
PSA, Free Human 
SCCA Human 
t-PSA Human

Share: